Induction chemotherapy combined with immunotherapy in locally advanced head and neck squamous cell carcinoma

BACKGROUND: This study aimed to explore the efficacy and safety of sintilimab combined with induction chemotherapy (IC) in locally advanced head and neck squamous cell carcinoma (HNSCC) patients. METHODS: A total of 163 patients were prospectively enrolled; 98 patients received IC only, and 65 patie...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMC Cancer
Egile Nagusiak: Li, Xia, Fang, Qigen, Du, Wei, Zhang, Xu, Dai, Liyuan, Qiao, Yongming
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2021
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8157730/
https://ncbi.nlm.nih.gov/pubmed/34044810
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-021-08373-8
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak